Loss of Mir-146a Function in Hormone-refractory Prostate Cancer

Overview

Journal RNA

Specialty Molecular Biology

Date 2008 Jan 5

PMID 18174313

Citations 169

Authors

Shi-Lung Lin

Angela Chiang

Donald Chang

Shao-Yao Ying

Affiliations

Soon will be listed here.

Abstract

The pattern of microRNA (miRNA) expression is associated with the degree of tumor cell differentiation in human prostate cancer. MiRNAs bind complementarily to either oncogenes or tumor suppressor genes, which are consequently silenced, resulting in alterations of tumorigenecity. We have detected eight down-regulated and three up-regulated known miRNAs in androgen-independent human prostate cancer cells compared to those in androgen-dependent cells, using miRNA microarray analyses. These identified miRNAs showed the same expression patterns in hormone-refractory prostate carcinomas (HRPC) compared to androgen-sensitive noncancerous prostate epithelium as determined by fluorescent in situ hybridization assays in human prostate cancer tissue arrays. One of the eight down-regulated miRNAs, mir-146a, was selected and constitutively expressed to examine its effects on suppression of prostate cancer transformation from androgen-dependent to -independent cells as determined by in vitro tumorigenecity assays. Transfection of mir-146a, which perpetually express the miRNA, suppressed >82% of the expression of the targeted protein-coding gene, ROCK1, in androgen-independent PC3 cells, consequently markedly reducing cell proliferation, invasion, and metastasis to human bone marrow endothelial cell monolayers. Given that ROCK1 is one of the key kinases for the activation of hyaluronan (HA)-mediated HRPC transformation in vivo and in PC3 cells, mir-146a may function as a tumor-suppressor gene in modulating HA/ROCK1-mediated tumorigenecity in androgen-dependent prostate cancer.

Citing Articles

Expression and Functional Analysis of Immuno-Micro-RNAs mir-146a and mir-326 in Colorectal Cancer.

Farc O, Budisan L, Zaharie F, Taulean R, Valean D, Talvan E Curr Issues Mol Biol. 2024; 46(7):7065-7085.

PMID: 39057062 PMC: 11276483. DOI: 10.3390/cimb46070421.

Monolayer culture alters EGFR inhibitor response through abrogation of microRNA-mediated feedback regulation.

Florio A, Johnson S, Salvatori R, Vasmatzis G Sci Rep. 2024; 14(1):7303.

PMID: 38538642 PMC: 10973516. DOI: 10.1038/s41598-024-56920-7.

Inflammation and tumor microenvironment.

Niu T, Zhou F Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 48(12):1899-1913.

PMID: 38448384 PMC: 10930746. DOI: 10.11817/j.issn.1672-7347.2023.230231.

Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study.

Pessoa R, de Souza D, Nukui Y, Pereira J, Fernandes L, Marcusso R Int J Mol Sci. 2023; 24(13).

PMID: 37445821 PMC: 10342019. DOI: 10.3390/ijms241310643.

Emerging roles of noncoding RNAs in human cancers.

Wu S, Wu Y, Deng S, Lei X, Yang X Discov Oncol. 2023; 14(1):128.

PMID: 37439905 PMC: 10344860. DOI: 10.1007/s12672-023-00728-w.

References

Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12(9):735-9. DOI: 10.1016/s0960-9822(02)00809-6. View

Somlyo A, Phelps C, diPierro C, Eto M, Read P, Barrett M . Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. FASEB J. 2003; 17(2):223-34. DOI: 10.1096/fj.02-0655com. View

Lin S, Chang D, Wu D, Ying S . A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun. 2003; 310(3):754-60. DOI: 10.1016/j.bbrc.2003.09.070. View

Rodriguez-Viciana P, Warne P, Vanhaesebroeck B, Waterfield M, Downward J . Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 1996; 15(10):2442-51. PMC: 450176. View

Lin S, Chang S, Ying S . Transgene-like animal models using intronic microRNAs. Methods Mol Biol. 2006; 342:321-34. DOI: 10.1385/1-59745-123-1:321. View

Porkka K, Pfeiffer M, Waltering K, Vessella R, Tammela T, Visakorpi T . MicroRNA expression profiling in prostate cancer. Cancer Res. 2007; 67(13):6130-5. DOI: 10.1158/0008-5472.CAN-07-0533. View

Litvinov I, Antony L, Dalrymple S, Becker R, Cheng L, Isaacs J . PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Prostate. 2006; 66(12):1329-38. DOI: 10.1002/pros.20483. View

Lin S, Chang D, Ying S . Hyaluronan stimulates transformation of androgen-independent prostate cancer. Carcinogenesis. 2006; 28(2):310-20. DOI: 10.1093/carcin/bgl134. View

Jagla M, Feve M, Kessler P, Lapouge G, Erdmann E, Serra S . A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions. Endocrinology. 2007; 148(9):4334-43. DOI: 10.1210/en.2007-0446. View

10.

De Benedetti A, Graff J . eIF-4E expression and its role in malignancies and metastases. Oncogene. 2004; 23(18):3189-99. DOI: 10.1038/sj.onc.1207545. View

11.

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

12.

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

13.

Reis E, Nakaya H, Louro R, Canavez F, Flatschart A, Almeida G . Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene. 2004; 23(39):6684-92. DOI: 10.1038/sj.onc.1207880. View

14.

GROSSMANN M, Huang H, Tindall D . Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst. 2001; 93(22):1687-97. DOI: 10.1093/jnci/93.22.1687. View

15.

Paszek M, Zahir N, Johnson K, Lakins J, Rozenberg G, Gefen A . Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8(3):241-54. DOI: 10.1016/j.ccr.2005.08.010. View

16.

Bourguignon L, Singleton P, Zhu H, Diedrich F . Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor.... J Biol Chem. 2003; 278(32):29420-34. DOI: 10.1074/jbc.M301885200. View